Beth

Press Release

Positive Phase 3a Data for oral semaglutide formulation should help drive Novo Nordisk’s T2D drug to blockbuster status

Following today’s news (Thursday 28 June) that Novo Nordisk achieved positive top-line results in its Phase 3a trial for oral semaglutide in type 2 diabetes patients, Tom Moore, Healthcare Analyst at GlobalData, a leading data and analytics company, offers his view: “Novo Nordisk has been able to further strengthen its type 2 diabetes (T2D) portfolio […]

Technology

T-Systems’ planned cuts will create a leaner business, but changes come with new risk

Following the recent announcement that Deutsche Telekom’s global B2B unit T-Systems began implementing a new transformation plan, John Marcus, Principal Analyst for Enterprise Services at GlobalData, a leading data and analytics company, comments on the operational changes ahead for the German ICT service provider: “T-Systems hired new CEO Adel Al-Saleh late last year to lead […]

Press Release

GW Pharmaceuticals hitting new highs with FDA approval of cannabis-based Epidiolex

The US Food and Drug Administration (FDA) has just approved GW Pharmaceuticals’ lead pipeline candidate, Epidiolex, for the treatment of rare, pediatric epilepsy conditions – but why the fuss? Well, for one, it looks to address significant unmet need in the epilepsy market, but more importantly; the drug is a marijuana based-cannabidiol which, according to […]

Press Release

Immune-based gene therapy candidates should prevail in oncology

Gene therapy combines a reduced treatment duration with a higher chance of cure unlike conventional oncology treatments such as chemotherapy. However this novel therapeutic approach requires the delivery of genetic material to the patient, an uncharted territory in oncology which will necessitate the implementation of new regulatory guidelines and the restructuring of existing treatment algorithms […]

Press Release

Over half of UK individuals are not accessing financial advice

Financial services must do more to narrow the advice gap in the UK as currently 56.5% of individuals are not accessing financial advice, according to GlobalData, a leading data and analytics company. GlobalData’s latest report: ‘Customer Engagement with Financial Advice’ states that the industry should seek to engage those currently underserved in the advice space. […]

Press Release

Price comparison websites helping to revive UK insurance brokers

Brokers continue to dominate commercial insurance distribution, as the channel’s UK market share is expected to have grown in 2017 to an estimated footprint of £13.3bn. Brokers’ market influence grew for the first time in years in 2016, largely at the expense of the direct channel, according to GlobalData, a leading data and analytics company, […]

Press Release

Over 30% of UK consumers would consider switching to Google, Amazon or Facebook for insurance

The UK insurance market remains vulnerable to the entrance of ‘alternative providers’ such as Google, Apple, Facebook and Amazon (GAFA), with over 30% of consumers saying they would purchase some form of insurance product from certain providers, according to GlobalData, a leading data and analytics company. This suggests an opening potential of around £9bn in […]

Press Release

£215bn of UK millionaires’ wealth will be inherited over the next 10 years

The majority of wealth managers around the world agree that intergenerational wealth transfers will be a big source of business for the industry in the near future, according to GlobalData, a leading data and analytics company. The company’s latest report, ‘2018: Trends to Watch in Global Wealth Management’, identified intergenerational wealth transfer as one of […]

Press Release

Age-related macular degeneration market will rocket to $11.5bn by 2026

Pharmaceutical sales within the age-related macular degeneration (AMD) markets were estimated to be $4.9bn across the seven major markets (7MM*) in 2016. This is expected to reach $11.5bn in 2026, at an impressive Compound Annual Growth Rate (CAGR) of 8.9%, according to GlobalData, a leading data and analytics company. The company’s report: ‘PharmaPoint: Age-Related Macular […]

Prev 1 … 91 92 93

Positive Phase 3a Data for oral semaglutide formulation should help drive Novo Nordisk’s T2D drug to blockbuster status

T-Systems’ planned cuts will create a leaner business, but changes come with new risk

GW Pharmaceuticals hitting new highs with FDA approval of cannabis-based Epidiolex

Immune-based gene therapy candidates should prevail in oncology

Over half of UK individuals are not accessing financial advice

Price comparison websites helping to revive UK insurance brokers

Over 30% of UK consumers would consider switching to Google, Amazon or Facebook for insurance

£215bn of UK millionaires’ wealth will be inherited over the next 10 years

Age-related macular degeneration market will rocket to $11.5bn by 2026

Browse

Company information